BRIEF published on 05/17/2024 at 15:05, 1 year 6 months ago Protenus reconnu pour l'excellence en milieu de travail en 2024 Protenus Analyse Des Soins De Santé La Satisfaction Des Employés Excellence Du Lieu De Travail Certification Great Place To Work
BRIEF published on 05/17/2024 at 15:05, 1 year 6 months ago Protenus Recognized for Workplace Excellence in 2024 Employee Satisfaction Protenus Healthcare Analytics Workplace Excellence Great Place To Work Certification
PRESS RELEASE published on 05/17/2024 at 15:00, 1 year 6 months ago Protenus Earns Esteemed Workplace Honors for 2024 Protenus recognized as one of the 2024 Modern Healthcare Best Places to Work in Healthcare and a Great Place to Work® for the fifth year, highlighting commitment to employee well-being and workplace culture Healthcare Compliance Work-life Balance Protenus Great Place To Work® Employee-centric Culture
BRIEF published on 04/04/2024 at 16:05, 1 year 8 months ago Protenus remporte un accord de solutions logicielles de détournement de médicaments avec Premier, Inc. Protenus Conformité Des Soins De Santé Premier Inc. Prévention Du Détournement De Drogues Technologie De Surveillance
BRIEF published on 04/04/2024 at 16:05, 1 year 8 months ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Healthcare Compliance Protenus Premier Inc. Drug Diversion Prevention Surveillance Technology
PRESS RELEASE published on 04/04/2024 at 16:00, 1 year 8 months ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Protenus awarded national group purchasing agreement with Premier, Inc. for Drug Diversion Software Solutions, offering Premier members special pricing and terms for Protenus solution Healthcare Protenus Premier Inc. Drug Diversion Supplier Contract
BRIEF published on 04/02/2024 at 16:05, 1 year 8 months ago Protenus Secures Two Innovative Patents for Enhancing Healthcare Compliance Healthcare Compliance Protenus Patient Privacy Monitoring Technology Innovation U.S. Patents
BRIEF published on 04/02/2024 at 16:05, 1 year 8 months ago Protenus obtient deux brevets innovants pour améliorer la conformité des soins de santé Innovation Technologique Protenus Conformité Des Soins De Santé Surveillance De La Confidentialité Des Patients Brevets Américains
PRESS RELEASE published on 04/02/2024 at 16:00, 1 year 8 months ago Protenus Granted Two New Patents for Healthcare Compliance Protenus expands patient privacy monitoring technology with new patents to help hospitals identify record breaches. CEO emphasizes AI-driven solutions for protecting patient data Protenus Healthcare Compliance Analytics Patient Privacy Monitoring New Patents Data Breach
BRIEF published on 03/26/2024 at 16:05, 1 year 8 months ago Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology Artificial Intelligence Healthcare Compliance Protenus Drug Diversion Surveillance Patent Grant
Published on 12/05/2025 at 02:35, 4 hours 4 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 39 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 34 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 39 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 9 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 48 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 14 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 24 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 29 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 24 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
